REC 467Alternative Names: REC-0467; REC-467
Latest Information Update: 12 Oct 2015
At a glance
- Originator Recordati
- Mechanism of Action Proton pump inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Gastro-oesophageal reflux
Most Recent Events
- 07 Jun 2011 Preclinical trials in Gastro-oesophageal reflux in Europe (PO)